TLR4 promotes cryptosporidium parvum clearance in a mouse model of biliary cryptosporidiosis

Journal of Parasitology

Volumn 97, Issue 5, 2011, Pages 813-821

  O'Hara, Steven P ^a   Tietz Bogert, Pamela S ^a   Trussoni, Christy E ^a   Chen, Xianming ^a,b   Larusso, Nicholas F ^a  

^a MAYO CLINIC   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLINE; GAMMA INTERFERON; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

CELL ORGANELLE; DATA SET; ENZYME ACTIVITY; HISTOLOGY; INFECTIVITY; INFILTRATION; MICROBIAL ACTIVITY; NUMERICAL MODEL; OBSERVATIONAL METHOD; PARASITIC DISEASE; PATHOGENICITY; PATHOLOGY; PHYSIOLOGICAL RESPONSE; POLYSACCHARIDE; PROTOZOAN; RODENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE; BILIARY CRYPTOSPORIDIOSIS; BILIARY TRACT INFECTION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INFLAMMATORY CELL; LIVER CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OOCYST; PARASITE CLEARANCE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILE DUCT DISEASES; BILE DUCTS, INTRAHEPATIC; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOKINES; DISEASE MODELS, ANIMAL; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 4;

CRYPTOSPORIDIUM PARVUM; MUS; NEGIBACTERIA;

EID: 80053987111     PISSN: 00223395     EISSN: 19372345     Source Type: Journal    
DOI: 10.1645/GE-2703.1     Document Type: Article

References (49)

1. AKIRA, S., AND K. TAKEDA. 2004. Toll-like receptor signalling. Nature Reviews in Immunology 4: 499-511. (Pubitemid 38931765)
2. CAMPBELL, A. T., L. J. ROBERTSON, AND H. V. SMITH. 1992. Viability of Cryptosporidium parvum oocysts: Correlation of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes. Applied and Environmental Microbiology 58: 3488-3493.
3. CAMPBELL, L. D., J. N. STEWART, AND J. R. MEAD. 2002. Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokinereceptor knockout mice. Journal of Parasitology 88: 1014-1016. (Pubitemid 35278754)
4. CHEN, W., J. A. HARP, AND A. G. HARMSEN. 1993. Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infection and Immunity 61: 3928-3932. (Pubitemid 23260069)
5. CHEN, X. M., J. S. KEITHLY, C. V. PAYA, AND N. F. LARUSSO. 2002. Cryptosporidiosis. New England Journal of Medicine 346: 1723-1731. (Pubitemid 34547487)
6. Chen X.M.J.S. KeithlyC.V. PayaN.F. LarussoS.A. LevineP.L. SplinterP.S. TietzA.L. GanongC. JobinG.J. GoresC.V. PayaN.F. Larusso 2001 Cryptosporidium parvum activates nuclear factor kappaB in biliary epithelia preventing epithelial cell apoptosis Gastroenterology 120 1774-1783 (Pubitemid 32523495)
7. -, S. P. OHARA, J. B. NELSON, P. L. SPLINTER, A. J. SMALL, P. S. TIETZ, A. H. LIMPER, AND N. F. LARUSSO. 2005. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NFkappaB. Journal of Immunology 175: 7447-7456. (Pubitemid 41713442)
8. -, P. L. SPLINTER, S. P. OHARA, AND N. F. LARUSSO. 2007. A cellular micro-RNA, let-7i, regulates toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. Journal of Biological Chemistry 282: 28929-28938. (Pubitemid 47610421)
9. CRUICKSHANK, S. M., J. SOUTHGATE, P. J. SELBY, AND L. K. TREJDOSIEWICZ. 1998. Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. Journal of Hepatology 29: 550-558. (Pubitemid 28484943)
10. DEMETRIS, A. J., J. G. LUNZ 3RD, S. SPECHT, AND I. NOZAKI. 2006. Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World Journal of Gastroenterology 12: 3512-3522. (Pubitemid 43997028)
11. DIEHL, S., J. ANGUITA, A. HOFFMEYER, T. ZAPTON, J. N. IHLE, E. FIKRIG, AND M. RINCON. 2000. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13: 805-815. (Pubitemid 32041803)
12. EHIGIATOR, H. N., P. ROMAGNOLI, K. BORGELT, M. FERNANDEZ, N. MCNAIR, W. E. SECOR, AND J. R. MEAD. 2005. Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice. Parasite Immunology 27: 17-28. (Pubitemid 40524989)
13. GOMEZ MORALES, M. A., R. MELE, A. LUDOVISI, F. BRUSCHI, F. TOSINI, R. RIGANO, AND E. POZIO. 2004. Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins. Infection and Immunity 72: 1306-1310. (Pubitemid 38263749)
14. GRUBMAN, S. A., R. D. PERRONE, D. W. LEE, S. L.MURRAY, L. C. ROGERS, L. I.WOLKOFF, A. E.MULBERG, V. CHERINGTON, AND D. M. JEFFERSON. 1994. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. American Journal of Physiology 266: G1060-1070.
15. HARADA, K., K. OHBA, S. OZAKI, K. ISSE, T. HIRAYAMA, A. WADA, AND Y. NAKANUMA. 2004. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 40: 925-932. (Pubitemid 39288126)
16. -, S. SHIMODA, Y. SATO, K. ISSE, H. IKEDA, AND Y. NAKANUMA. 2009. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clinical and Experimental Immunology 157: 261-270.
17. LACROIX, S., R. MANCASSOLA, M. NACIRI, AND F. LAURENT. 2001. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: Role of tumor necrosis factor alpha in protection. Infection and Immunity 69: 1635-1642. (Pubitemid 32187620)
18. LAURENT, F., L. ECKMANN, T. C. SAVIDGE, G. MORGAN, C. THEODOS, M. NACIRI, AND M. F. KAGNOFF. 1997. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infection and Immunity 65: 5067-5073. (Pubitemid 27513551)
19. -, M. F. KAGNOFF, T. C. SAVIDGE, M. NACIRI, AND L. ECKMANN. 1998. Human intestinal epithelial cells respond to Cryptosporidium parvum infection with increased prostaglandin H synthase 2 expression and prostaglandin E2 and F2alpha production. Infection and Immunity 66: 1787-1790.
20. LAZARIDIS, K. N., M. STRAZZABOSCO, AND N. F. LARUSSO. 2004. The cholangiopathies: Disorders of biliary epithelia. Gastroenterology 127: 1565-1577. (Pubitemid 39457780)
21. LEAN, I. S., S. LACROIX-LAMANDE, F. LAURENT, AND V. MCDONALD. 2006. Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection. Infection and Immunity 74: 4379-4382. (Pubitemid 43993375)
22. MCDONALD, V., R. DEER, S. UNI, M. ISEKI, AND G. J. BANCROFT. 1992. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infection and Immunity 60: 3325-3331.
23. -, R. SMITH, H. ROBINSON, AND G. BANCROFT. 2000. Host immune responses against Cryptosporidium. Contributions to Microbiology 6: 75-91.
24. MENG, F., Y. YAMAGIWA, Y. UENO, AND T. PATEL. 2006. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes. Journal of Hepatology 44: 1055-1065. (Pubitemid 44308229)
25. MODLIN, R. L., AND G. CHENG. 2004. From plankton to pathogen recognition. Nature Medicine 10: 1173-1174. (Pubitemid 39540431)
26. MORITA, M., Y.WATANABE, AND T. AKAIKE. 1994. Inflammatory cytokines up-regulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion. Hepatology 19: 426-431. (Pubitemid 24046788)
27. OHARA, S. P., A. J. SMALL, G. B. GAJDOS, A. D. BADLEY, X. M. CHEN, AND N. F. LARUSSO. 2009. HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum. Journal of Infectious Diseases 199: 1195-1204.
28. -, J. R. YU, AND J. J. LIN. 2004. A novel Cryptosporidium parvum antigen, CP2, preferentially associates with membranous structures. Parasitology Research 92: 317-327. (Pubitemid 38339988)
29. OKADA, K., Y. SHIMIZU, S. NAMBU, K. HIGUCHI, AND A. WATANABE. 1994. Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line. Journal of Gastroenterology and Hepatology 9: 462-467. (Pubitemid 24312840)
30. PARK, J., G. J. GORES, AND T. PATEL. 1999. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase. Hepatology 29: 1037-1043. (Pubitemid 29168733)
31. PONNURAJ, E. M., AND A. R. HAYWARD. 2002. Requirement for TNFTnfrsf1 signalling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum. Clinical and Experimental Immunology 128: 416-420. (Pubitemid 34639301)
32. RINCON, M., J. ANGUITA, T. NAKAMURA, E. FIKRIG, AND R. A. FLAVELL. 1997. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. Journal of Experimental Medicine 185: 461-469. (Pubitemid 27078364)
33. ROGERS, K. A., A. B. ROGERS, B. A. LEAV, A. SANCHEZ, E. VANNIER, S. UEMATSU, S. AKIRA, D. GOLENBOCK, AND H. D. WARD. 2006. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice. Infection and Immunity 74: 549-556. (Pubitemid 43023110)
34. SCHNARE, M., G. M. BARTON, A. C. HOLT, K. TAKEDA, S. AKIRA, AND R. MEDZHITOV. 2001. Toll-like receptors control activation of adaptive immune responses. Nature Immunology 2: 947-950. (Pubitemid 32976167)
35. SCHOLZ, M., J. CINATL, R. A. BLAHETA, B. KORNHUBER, B. H. MARKUS, AND H. W. DOERR. 1997. Expression of human leukocyte antigens class I and class II on cultured biliary epithelial cells after cytomegalovirus infection. Tissue Antigens 49: 640-643. (Pubitemid 27267886)
36. SELMI, C., I. R. MACKAY, AND M. E. GERSHWIN. 2007. The immunological milieu of the liver. Seminars in Liver Disease 27: 129-139. (Pubitemid 46871659)
37. SEYDEL, K. B., T. ZHANG, G. A. CHAMPION, C. FICHTENBAUM, P. E. SWANSON, S. TZIPORI, J. K. GRIFFITHS, AND S. L. STANLEY, JR. 1998. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infection and Immunity 66: 2379-2382. (Pubitemid 28194149)
38. STEPHENS, J., M. COSYNS, M. JONES, AND A. HAYWARD. 1999. Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice. Hepatology 30: 27-35. (Pubitemid 29300565)
39. SUNG, J. Y., J. W. COSTERTON, AND E. A. SHAFFER. 1992. Defense system in the biliary tract against bacterial infection. Digestive Disease Science 37: 689-696.
40. TAKEDA, K., T. KAISHO, AND S. AKIRA. 2003. Toll-like receptors. Annual Reviews in Immunology 21: 335-376. (Pubitemid 37174535)
41. THEODOS, C. M. 1998. Innate and cell-mediated immune responses to Cryptosporidium parvum. Advances in Parasitology 40: 87-119. (Pubitemid 30411806)
42. -, K. L. SULLIVAN, J. K. GRIFFITHS, AND S. TZIPORI. 1997. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: The extent of gamma interferon modulation determines the outcome of infection. Infection and Immunity 65: 4761-4769. (Pubitemid 27463254)
43. TRAUNER, M., P. FICKERT, AND R. E. STAUBER. 1999. Inflammationinduced cholestasis. Journal of Gastroenterology and Hepatology 14: 946-959.
44. UNGAR, B. L., T. C. KAO, J. A. BURRIS, AND F. D. FINKELMAN. 1991. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. Journal of Immunology 147: 1014-1022.
45. VERDON, R., J. POLIANSKI, A. GRODET, L. GARRY, AND C. CARBON. 1998. Cryptosporidium parvum biliary tract infection in adult immunocompetent and immunosuppressed mice. Journal of Medical Microbiology 47: 71-77. (Pubitemid 28025468)
46. WATERS, W. R., AND J. A. HARP. 1996. Cryptosporidium parvum infection in T-cell receptor (TCR)-alpha- and TCR-delta-deficient mice. Infection and Immunity 64: 1854-1857.
47. WEHBE, H., R. HENSON, F. MENG, J. MIZE-BERGE, AND T. PATEL. 2006. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Research 66: 10517-10524. (Pubitemid 44799774)
48. WYATT, C. R., E. J. BRACKETT, L. E. PERRYMAN, A. C. RICE-FICHT, W. C. BROWN, AND K. I. OROURKE. 1997. Activation of intestinal intraepithelial T lymphocytes in calves infected with Cryptosporidium parvum. Infection and Immunity 65: 185-190. (Pubitemid 27008921)
49. YE, Y., X. XIE, J. YU, L. ZHOU, H. XIE, G. JIANG, X. YU, W. ZHANG, J. WU, AND S. ZHENG. 2010. Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. Journal of Clinical Immunology 30: 546-555.